ANDA 40810, held by Sun Pharm Inds Inc. Hydrochlorothiazide.
As of Nov 16, 2026, ANDA 40810 (Hydrochlorothiazide), held by Sun Pharm Inds Inc, was first approved by FDA on Mar 27, 2007, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 27, 2007 | Original application | Approved | None posted |
| Hydrochlorothiazide25MG · tablet;oral | Hydrochlorothiazide | Discontinued |
| Hydrochlorothiazide50MG · tablet;oral | Hydrochlorothiazide | Discontinued |
| Aug 20, 2020 | Supplement 9Labeling · Standard review | Approved | None posted |
| Mar 27, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters